Scarica l'app Stockscreener
87.29
1.02%
0.88
Dopo l'orario di chiusura:
87.88
0.59
+0.68%
Precedente Chiudi:
$86.41
Aprire:
$86.66
Volume 24 ore:
860.76K
Relative Volume:
0.96
Capitalizzazione di mercato:
$14.86B
Reddito:
$8.28B
Utile/perdita netta:
$1.43B
Rapporto P/E:
10.69
EPS:
8.1642
Flusso di cassa netto:
$-203.00M
1 W Prestazione:
-0.64%
1M Prestazione:
-3.04%
6M Prestazione:
+31.90%
1 anno Prestazione:
+21.57%
Intervallo 1D:
$86.66
$88.23
Intervallo di 1 settimana:
$85.25
$88.93
Portata 52W:
$62.38
$94.16
Solventum Corp Stock (SOLV) Company Profile
Nome
Solventum Corp
Settore
Industria
Telefono
651-733-1110
Indirizzo
1750 YANKEE DOODLE ROAD, EAGAN
Compare SOLV vs ISRG, BDX, RMD, MDLN, ALC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
87.29 | 14.86B | 8.28B | 1.43B | -203.00M | 8.1642 |
ISRG
Intuitive Surgical Inc
|
423.96 | 149.78B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
183.75 | 50.05B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
230.05 | 32.35B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
36.26 | 31.81B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
64.11 | 30.99B | 10.63B | 819.00M | 1.59B | 1.6577 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-07-28 | Aggiornamento | UBS | Neutral → Buy |
| 2026-07-09 | Iniziato | BMO Capital Markets | Market Perform |
| 2026-05-15 | Iniziato | Wedbush | Outperform |
| 2026-05-14 | Downgrade | UBS | Buy → Neutral |
| 2026-03-24 | Iniziato | Rothschild & Co Redburn | Sell |
| 2026-01-26 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2026-01-20 | Aggiornamento | Mizuho | Neutral → Outperform |
| 2025-12-02 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2025-10-01 | Iniziato | UBS | Neutral |
| 2025-09-11 | Iniziato | Jefferies | Hold |
| 2025-07-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | Aggiornamento | Argus | Hold → Buy |
| 2025-06-06 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-10-08 | Iniziato | Stifel | Buy |
| 2024-10-07 | Iniziato | Piper Sandler | Neutral |
| 2024-09-26 | Iniziato | Wolfe Research | Peer Perform |
| 2024-09-05 | Iniziato | BTIG Research | Neutral |
| 2024-06-24 | Iniziato | Argus | Hold |
| 2024-05-30 | Iniziato | Goldman | Sell |
| 2024-05-10 | Iniziato | BofA Securities | Neutral |
| 2024-04-10 | Iniziato | Morgan Stanley | Equal-Weight |
| 2024-04-08 | Iniziato | Wells Fargo | Equal Weight |
| 2024-04-02 | Iniziato | Edward Jones | Hold |
Mostra tutto
Solventum Corp Borsa (SOLV) Ultime notizie
China Sterilization Equipment Market Outlook to 2033Chemical, Physical and Ultraviolet Sterilizers | Revenue, Volume and Pricing Trends Reveal Growth Opportunities - GlobeNewswire Inc.
China Patient Examination Devices Market Size, Share, and Forecast to 2033Thermometers and Stethoscopes | Pricing Trends and Growth Opportunities Guide Expansion - GlobeNewswire Inc.
Can Solventum (SOLV) Keep the Earnings Surprise Streak Alive? - Zacks Investment Research
Why Solventum (SOLV) is a Top Value Stock for the Long-Term - Zacks Investment Research
Jefferies cuts Solventum stock price target to $34 on de-rating - Investing.com UK
Bair Hugger warming system wins Coolest Thing Made in Minnesota award - The Business Journals
US83444MAQ42 Bond Yield and Price — BONDSCOM:US83444MAQ42 - TradingView
Solventum Corp. stock falls Tuesday, underperforms market - MarketWatch
Wound Care Stocks Are Posting Double-Digit Growth. Here’s Why. - GlobeNewswire
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises - Zacks Investment Research
Solventum Corporation (SOLV) Stock Forecasts - Yahoo Finance
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names - Zacks Investment Research
SOLN5957384 Bond Profile: Coupon and Redemption - TradingView
SOLN5957404 Bond Profile: Coupon and Redemption - TradingView
Solventum Corporation (SOLV) stock price, news, quote and history - Yahoo Finance Australia
Solventum Corp. stock falls Wednesday, underperforms market - MarketWatch
SOLN5759822 Bond Profile: Coupon and Redemption - TradingView
ETFs Investing in Solventum Corporation Stocks - TradingView
How Is Solventum's Stock Performance Compared to Other Healthcare Stocks - Barchart.com
How Is Solventum's Stock Performance Compared to Other Healthcare Stocks - Yahoo Finance
Solventum (NYSE:SOLV) Forms Tight Breakout Setup as Technical Strength Builds - ChartMill
Solventum Corp (KB7.MU) latest press releases and corporate news - uk.finance.yahoo.com
Solventum Corporation (SOLV) Investor Outlook: Evaluating a 5.72% Upside with Robust ROE Metrics - DirectorsTalk Interviews
Solventum (SOLV) Q1 2026 Earnings Call Transcript - Fortune
Solventum: Divesture Unlocking Upside In A Spinoff Revaluation Play (NYSE:SOLV) - Seeking Alpha
Here's Why You Should Hold Solventum Stock in Your Portfolio for Now - Yahoo Finance
Solventum Corp Lobbyists, 2026 - OpenSecrets
Q2 Surgical Equipment & ConsumablesDiversified Earnings: Solventum (NYSE:SOLV) Impresses - Yahoo Finance
What Solventum (SOLV)'s Earnings Beat and Surgical AI Push Means For Shareholders - Yahoo Finance
Solventum Corp. stock falls Thursday, underperforms market - MarketWatch
Solventum at Wells Fargo 21st Annual Healthcare Conference: focus narrows By Investing.com - Investing.com South Africa
Solventum at Wells Fargo 21st Annual Healthcare Conference: focus narrows By Investing.com - Investing.com India
Solventum at Wells Fargo 21st Annual Healthcare Conference: focus narrows - investing.com
Solventum at Wells Fargo 21st Annual Healthcare Conference: focus narrows By Investing.com - Investing.com UK
Solventum Corp. stock falls Tuesday, underperforms market - MarketWatch
Hanson Bryan C Reports 185,515 Shares in Solventum After Exercising Options and Forfeiture - Kalkine Media
Solventum (SOLV) Up 11.4% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Solventum CEO Bryan Hanson Completes RSU Settlement and Share Withholding on September 1, 2026 - Kalkine Media
Is Solventum (SOLV) Fairly Valued On Raised 2026 Guidance Despite Debt And Cost Headwinds? - simplywall.st
Solventum Corp. stock rises Wednesday, outperforms market - MarketWatch
Solventum to Participate in the 2026 Wells Fargo Healthcare Conference - marketscreener.com
Solventum to Participate in the 2026 Wells Fargo Healthcare Conference - finance.yahoo.com
Should Investors Buy SOLV as Growth Improves but Debt Risks Persist? - Yahoo Finance
Solventum Corp stock hits 52-week high at 93.6 USD - investing.com
Solventum Corp stock hits 52-week high at 93.6 USD By Investing.com - Investing.com India
Solventum Corp stock hits 52-week high at 93.6 USD By Investing.com - Investing.com South Africa
Solventum Corp stock hits 52-week high at 90.05 USD - Investing.com India
Solventum Corp stock hits 52-week high at 90.05 USD By Investing.com - Investing.com Canada
Solventum Corp stock hits 52-week high at 90.05 USD By Investing.com - Investing.com Nigeria
Solventum Corp stock hits 52-week high at 90.05 USD By Investing.com - Investing.com UK
Solventum Corp Azioni (SOLV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Solventum Corp Azioni (SOLV) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| McMillan Wayde D. | Chief Financial Officer |
May 13 '26 |
Option Exercise |
0.00 |
9,503 |
0 |
53,041 |
| Harrington Paul S | Chief Supply Chain Officer |
May 13 '26 |
Option Exercise |
0.00 |
3,960 |
0 |
22,130 |
| Wilcox Mary T | Chief Accounting Officer |
May 13 '26 |
Option Exercise |
0.00 |
2,376 |
0 |
7,632 |
| Kirberger Marcela A. | Chief Legal Affairs Officer |
May 13 '26 |
Option Exercise |
0.00 |
4,488 |
0 |
15,492 |
| Hanson Bryan C | Chief Executive Officer |
May 13 '26 |
Option Exercise |
0.00 |
34,315 |
0 |
158,225 |
| Landucci Amy | Chief Information Officer |
May 13 '26 |
Option Exercise |
0.00 |
4,422 |
0 |
41,905 |
| Wendell Amy McBride | Director |
Apr 30 '26 |
Option Exercise |
0.00 |
3,403 |
0 |
10,422 |
| WEILAND JOHN H | Director |
Apr 30 '26 |
Option Exercise |
0.00 |
3,403 |
0 |
8,947 |
| Mily Elizabeth | Director |
Apr 30 '26 |
Option Exercise |
0.00 |
3,403 |
0 |
9,009 |
| Wilson Darryl L. | Director |
Apr 30 '26 |
Option Exercise |
0.00 |
3,403 |
0 |
8,947 |
1.88%
1.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):